Citigroup’s Sonoma Pharmaceuticals SNOA Stock Holding History

Citigroup’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,425	Closed	-$3.04K	–	6203
2026 Q1	$3.04K	Buy	+1,425	New	+$4.17K	﹤0.01%	5363
2025 Q4	–	Sell	-656	Closed	-$2.54K	–	6434
2025 Q3	$2.54K	Buy	+656	New	+$2.58K	﹤0.01%	5421
2025 Q2	–	Sell	-811	Closed	-$1.78K	–	5892
2025 Q1	$1.78K	Buy	+811	New	+$2.19K	﹤0.01%	5347
2024 Q4	–	Sell	-180	Closed	-$553	–	5949
2024 Q3	$553	Buy	+180	New	+$919	﹤0.01%	5477
2018 Q2	–	Hold	0	–	–	–	7728
2018 Q1	–	Hold	0	–	–	–	7665
2017 Q4	–	Hold	0	–	–	–	7643
2017 Q3	–	Hold	0	–	–	–	7424
2017 Q2	–	Hold	0	–	–	–	7465
2017 Q1	–	Hold	0	–	–	–	7326
2016 Q4	–	Hold	0	–	–	–	7318
2016 Q3	–	Hold	0	–	–	–	7188
2016 Q2	–	Hold	0	–	–	–	7404
2016 Q1	–	Sell	-1	Closed	-$929	–	7735
2015 Q4	$0	Buy	+1	New	+$1.07K	﹤0.01%	7839
2015 Q3	–	Sell	-2	Closed	-$2.37K	–	7685
2015 Q2	$3K	Buy	+2	New	+$1.87K	﹤0.01%	7015
2015 Q1	–	Sell	-1	Closed	-$850	–	7406
2014 Q4	$1K	Buy	+1	New	+$1.56K	﹤0.01%	6990
2014 Q3	–	Hold	0	–	–	–	7281
2014 Q2	–	Hold	0	–	–	–	6948
2014 Q1	–	Hold	0	–	–	–	6890
2013 Q4	–	Hold	0	–	–	–	6876
2013 Q3	–	Hold	0	–	–	–	6962
2013 Q2	–	Hold	0	–	–	–	6790

Other funds holding SNOA

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's SNOA Position: Q2 2026 in Review

Citigroup sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2026, closing a stake of 1,425 shares — an estimated $3.04K sold.

Citigroup first reported a position in SNOA in Q4 2014 and held it in 7 quarters. The position peaked at $3.04K in Q1 2026. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

Citigroup reported no remaining Sonoma Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Citigroup sold 1,425 Sonoma Pharmaceuticals shares in Q2 2026, an estimated $3.04K.
Citigroup first reported a position in Sonoma Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Citigroup's Sonoma Pharmaceuticals position peaked at $3.04K in Q1 2026.
14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.